• 中文版
  • Home
  • About Us
    • Contract Research Organization
    • Contract Development and Manufacturing Organization
    • Accolades
    • Publications
  • Services Overview
  • Discovery Chemistry
    • Synthetic Chemistry
    • Medicinal Chemistry
    • Library Chemistry
    • Peptide Chemistry
    • Fragment Based Screening
    • Computer Aided Drug Design
    • Analytical Services
    • Protein Structure
  • Biology & Pharmacology
    • Oncology
    • Pathology Core Facility
    • Immunology
    • Tumor Immunology
    • Neuroscience
    • Cell Biology
    • In Vitro Biology
      • Kinases
      • Epigenetics
      • GPCR, NR, Ion-channel, Transporter
      • Ubiquitin & PROTAC
      • KRAS
      • COVID-19
      • Radiometric
      • Customized assay development
      • High throughput screening
      • MOA Study
    • Metabolic & Cardiovascular Diseases
  • DMPK / Exploratory Toxicology
    • DMPK / Exploratory Toxicology
    • Biomarkers, Preclinical & Clinical Sample Bioanalysis
    • Large molecule PK/BA services
  • Biologics Discovery
    • Antibody Discovery
    • Protein Science
    • Biologics Analytical Services
    • B Cell Cloning
  • Biologics CMC
    • Stable Cell Line Development
    • Process Development
    • Formulation Development
    • Aseptic Filling and Freeze-drying
    • Drug Developability / Manufacturability study
    • Final Container Extractables & Leachables Study
    • Analytical Development and Testing
    • GMP Production
  • Small Molecule CMC
    • Process R&D Services
    • Process Safety
    • Analytical Development
    • Pre-Formulation Development
    • Formulation Development
    • ICH Stability Studies
    • CMC CTD Support
    • Manufacturing
  • Blog
  • Careers
  • News & Events
    • Webinars
  • Contact Us
  • Download Center

Call us today! +86 21 5132 0088

contact@chempartner.com
中文版
Shanghai ChemPartner Shanghai ChemPartner Shanghai ChemPartnerShanghai ChemPartner
  • Home
  • About Us
    • About ChemPartner
    • CRO
    • CDMO
    • Accolades
    • Publications
  • Services
    • Discovery Chemistry
      • Synthetic Chemistry
      • Medicinal Chemistry
      • Library Chemistry
      • Peptide Chemistry
      • Fragment Based Screening
      • Computer Aided Drug Design
      • Analytical Services
      • Protein Structure
    • Biology & Pharmacology
      • Oncology
      • Pathology Core Facility
      • Immunology
      • Tumor Immunology
      • Cell Biology
      • In Vitro Biology
      • Neuroscience
      • Metabolic & Cardiovascular Diseases
      • Epigenetics
    • DMPK / Exploratory Toxicology
      • DMPK / Exploratory Toxicology
      • Biomarkers, Preclinical & Clinical Sample Bioanalysis
      • Large molecule PK/BA services
    • Biologics Discovery
      • Antibody Discovery
      • Protein Science
      • Biologics Analytical Services
      • B Cell Cloning
    • Biologics CMC
      • Stable Cell Line Development
      • Process Development
      • Formulation Development
      • Aseptic Filling and Freeze-drying
      • Drug Developability / Manufacturability study
      • Final Container Extractables & Leachables Study
      • Analytical Development and Testing
      • GMP Production
    • Small Molecule CMC
      • Process R&D Services
      • Process Safety
      • Analytical Development
      • Pre-Formulation Development
      • Formulation Development
      • ICH Stability Studies
      • CMC CTD Support
      • Manufacturing
  • Blog
  • Careers
  • News & Events
    • Webinars
  • Contact Us
  • Download Center

Medicinal Chemistry

Home Discovery Chemistry Medicinal Chemistry

Medicinal Chemistry

At ChemPartner, our medicinal chemistry leaders all have over 10 years of international experience solving problems and driving projects forward. We have knowledgeable leaders on the ground in Shanghai, working shoulder-to-shoulder with your medicinal chemistry teams and clients may choose to work with our U.S.-based scientists who can provide dedicated design/leadership and project managemant support to their projects to drive their programs depending on individual discovery research needs. We have a long track record of delivering for our partners at all stages of drug discovery from HTS Triage, Hit Identification, Lead Identification, and Lead Optimization through to pre-clinical.

Hit confirmation

Our company began with synthetic chemistry and we have continuously honed our skills for over a decade. Our chemists and compound management group process 1000+ compounds per week. We use our synthesis skills at every stage of our medicinal chemistry projects. We can quickly and efficiently re-synthesize HTS hits for confirmation and quickly make analogs for series confirmation.

Hit Identification

Pairing our strength in synthetic chemistry with our experience in medicinal chemistry, and working closely with our HTS, FBS and DMPK colleagues, we can quickly identify hits from HTS or FBS campaigns or other starting points of the discovery process. After establishing Hit validity we map out a route to either quickly establish proof of concept in newer projects or triage structural classes in mature targets to identify several classes of Hits. ChemPartner has also recently established its own state of the art Fragment Based Screening service to enable in house hit ID.

Hit-to-Lead

Our chemists and project teams refine Hits into Lead status. Our experienced medicinal chemistry teams focus on the critical path assays to solve issues with potency, selectivity, ADME, etc. to quickly develop compounds into Leads by keeping cycle times low and utilizing our in-house computational and rational drug design strategies.

Lead optimization

Working with Leads, our project leaders focus on hypothesis-driven medicinal chemistry, matched pair techniques, and rational drug design to bring the projects Leads into pre-clinical status. Our biology and DMPK groups have a wide range of in vitro and in vivo assays for rapid analysis, and our project teams work closely together to minimize cycle time to quickly solve any remaining compound issues.

Computational Tools

Our exceptional computational chemistry group has a wide range of tools available to assess many aspects of Hits and Leads using a variety of technigues including both structure or logand based design. From assessing novelty and diversity of screening collections to using property filters to select monomers or establish correlations between physical properties and assay data, our project teams have access to any computational tools and expertise necessary.

Tailored Collaborations

We have extensive experience with many types of collaborations from simple chemistry support through ‘co-piloted’ projects where our partners share design responsibility with us and all the way to ‘set and forget’ where our partners simply provide the target and we take care of the entire project from HTS to identifying a Pre-Clinical compound. The cross-functional capability of ChemPartner allows for fully integrated service projects where we provide the entire discovery research teams in chemistry, biology and ADME. Our U.S.-based team of experienced medicinal chemists takes the integrated service model further by providing a sophisticated design and innovation partner, fully enabled by co-located CADD expertise, who can facilitate project team management and communication to meet the client’s specific requirements. We can add all or any additional experts from biology and DMPK etc.. No matter the collaboration parameters, our partners own all the IP generated from our efforts, and we rigorously guard all IP in a multi-tiered, proactive approach.

  • Service Overview
  • Discovery Chemistry
    • Synthetic Chemistry
    • Medicinal Chemistry
    • Library Chemistry
    • Peptide Chemistry
    • Fragment Based Screening
    • Computer Aided Drug Design
    • Analytical Services
    • Protein Structure
  • Biology & Pharmacology
    • Oncology
      • OncoCP Database
    • Pathology Core Facility
      • Histopathology
      • Molecular Pathology
    • Immunology
      • Primary immune cell assays
      • Immune cell line assays
      • Autoimmune disease models
      • In vivo PD models
      • Immune profiling for MOA
    • Tumor Immunology
    • Neuroscience
      • Volume Discount Fast services for Neuroscience
      • Behavioral Pharmacology
      • In vivo Pain Models
      • Non-Human Primate Cognition
      • In Vitro Electrophysiology
    • Cell Biology
      • Target Validation
      • Cell-based Assays
      • Cancer Cell Line Panel Screen
      • Biomarker Analysis
    • In Vitro Biology
      • Kinases
      • Epigenetics
      • GPCR, NR, Ion-channel, Transporter
      • Ubiquitin & PROTAC
      • KRAS
      • COVID-19
      • Radiometric
      • Customized assay development
      • High throughput screening
      • MOA Study
    • Metabolic & Cardiovascular Diseases
  • DMPK / Exploratory Toxicology
    • DMPK / Exploratory Toxicology
      • In vitro ADME
      • Pharmacokinetics
      • Exploratory Toxicology
      • Bioanalysis
      • Regulatory filing
    • Biomarkers, Preclinical & Clinical Sample Bioanalysis
    • Large molecule PK/BA services
      • Monoclonal Antibodies
      • Antibody Drug Conjugates
      • Bispecific Antibodies
      • Proteins & Peptides
      • Immunogenicity
  • Biologics Discovery
    • Antibody Discovery
      • Hybridoma
      • Antibody Engineering
      • Phage Display
      • Antibody-Drug Conjugate
    • Protein Science
    • Biologics Analytical Services
      • mAb Release Tests and Extended Characterization
      • Antibody-Drug Conjugate(ADC) Analysis
      • Therapeutic Protein Characterization
      • Biomolecular Interaction Analysis
    • B Cell Cloning
  • Biologics CMC
    • Stable Cell Line Development
    • Process Development
    • Formulation Development
    • Aseptic Filling and Freeze-drying
    • Drug Developability / Manufacturability study
    • Final Container Extractables & Leachables Study
    • Analytical Development and Testing
    • GMP Production
  • Small Molecule CMC
    • Process R&D Services
    • Process Safety
    • Analytical Development
    • Pre-Formulation Development
    • Formulation Development
    • ICH Stability Studies
    • CMC CTD Support
    • Manufacturing

Give us a Message

You can leave us a message by quick contact box and we'll get back to you, asap. Thanks!

Send Message

Logo

ChemPartner is a leading research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry.

Get started today.

Contact Us
  • Shanghai ChemPartner Co., Ltd.
  • 1F & 3F, Block A, 2829 JinKe Road, Zhangjiang Hi-Tech Park, PuDong New Area, Shanghai China, 201203
  • +86 21 5132 0088
  • contact@chempartner.com

© 2021 — Shanghai ChemPartner Co., Ltd. All Rights Reserved  About Us  Careers  Contact Us  Privacy Policy  Sitemap

  • Home
  • Contact
  • Buy Highend